Not applicableStudy completedNCT05711290What this trial is testingOxygen Nanobubble Drink Impact on Exercise in Pulmonary FibrosisWho this might be right forPulmonary Fibrosis University of Oxford 28
Not applicableLooking for participantsNCT06310915What this trial is testingOral Chemotherapeutic Drugs Were Analyzed in Patients With Driver Gene Negative Locally Advanced/Advanced Non-small Cell Lung Cancer With PS Score 2 A Prospective, Single-arm, Multicenter, Observational Study on the Efficacy and Safety of Radiochemotherapy Combined With PD-1 InhibitorWho this might be right forNon-small Cell Lung Cancer Stage IIIB/IV Guangzhou Institute of Respiratory Disease 30
Early research (Phase 1)Study completedNCT06294561What this trial is testingTGRX-326 Pharmacokinetic Drug InteractionWho this might be right forNon Small Cell Lung Cancer Shenzhen TargetRx, Inc. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320What this trial is testingA Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more Immuneering Corporation 209
Early research (Phase 1)Study completedNCT00589381What this trial is testingFenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00008333What this trial is testingVinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 59
Large-scale testing (Phase 3)Study completedNCT01979952What this trial is testingNintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)Who this might be right forIdiopathic Pulmonary Fibrosis Boehringer Ingelheim 113
Early research (Phase 1)Looking for participantsNCT06586957What this trial is testingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more NiKang Therapeutics, Inc. 150
Not applicableStudy completedNCT06686602What this trial is testingA Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast CancerWho this might be right forAdvanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer Daiichi Sankyo 13,759
Testing effectiveness (Phase 2)UnknownNCT05675605What this trial is testingTY-1091 in Patients With Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more TYK Medicines, Inc 248
Early research (Phase 1)Study completedNCT00019656What this trial is testingPerifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+2 more National Cancer Institute (NCI)
Not applicableStudy completedNCT06990022What this trial is testingCarbohydrate Mouth Rinse (Small-Sided Soccer Games)Who this might be right forPerformanceSoccerCarbohydrate+2 more Tokat Gaziosmanpasa University 16
Testing effectiveness (Phase 2)Study completedNCT02414139What this trial is testingStudy of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)Who this might be right forCarcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals 373
Large-scale testing (Phase 3)Study completedNCT00430105What this trial is testingPulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated VasculitidesWho this might be right forANCA Associated Systemic VasculitisWegener's GranulomatosisMicroscopic Polyangiitis Cambridge University Hospitals NHS Foundation Trust 160
Early research (Phase 1)Ended earlyNCT01528137What this trial is testingTalactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+43 more Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT01806675What this trial is testing18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Ended earlyNCT00503971What this trial is testingPhase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.Who this might be right forNon-small Cell Lung Cancer Spanish Lung Cancer Group 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06518850What this trial is testingStudy of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal DistensionWho this might be right forSmall Intestine Bacterial Overgrowth Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 818
Early research (Phase 1)Study completedNCT00856037What this trial is testingTopotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung CancerWho this might be right forRecurrent Small Cell Lung Carcinoma University of Nebraska 22